Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
about
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacinLevofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureusAccidental overdose of intravenous ofloxacin with benign outcome.Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilisTreatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic studyComparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers
P2860
Q24670225-EF5B1632-DC00-4919-87B5-D8B6BBA46410Q28379074-FE9A94AD-B412-4C72-BE86-DFA3E53E54BAQ33744549-8447090C-EB64-4FFC-A279-2284B951B52FQ33976236-2E4B50F0-3F4D-4980-9745-D25F9D928855Q34732986-AEA12808-545F-407E-9F21-C9006D62E821Q35353352-3CD9A16D-D7C9-4426-99A8-B2705DA15877Q36754888-BE6EC12D-5AA3-43F3-AA43-4063E0300F5BQ39559768-EB111D8E-9ECD-4616-9FD2-85BF380EE227Q39816080-2823AF8B-4F06-46A1-98D2-3388AC6ABC68
P2860
Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1988
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy, safety, and potentia ...... n the treatment of infections.
@en
Efficacy, safety, and potentia ...... n the treatment of infections.
@nl
type
label
Efficacy, safety, and potentia ...... n the treatment of infections.
@en
Efficacy, safety, and potentia ...... n the treatment of infections.
@nl
prefLabel
Efficacy, safety, and potentia ...... n the treatment of infections.
@en
Efficacy, safety, and potentia ...... n the treatment of infections.
@nl
P1476
Efficacy, safety, and potentia ...... n the treatment of infections.
@en
P2093
Sanders WE Jr
P304
P577
1988-05-01T00:00:00Z